These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36465638)

  • 21. Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome.
    Nyunt O; Cotterill AM; Archbold SM; Wu JY; Leong GM; Verge CF; Crock PA; Ambler GR; Hofman P; Harris M
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E464-7. PubMed ID: 20810574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prader-Willi syndrome: endocrine manifestations and management.
    Alves C; Franco RR
    Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Prader-Labhart-Willi syndrome in children and in adults, with particular emphasis on the treatment with recombinant human growth hormone.
    Drabik M; Lewiński A; Stawerska R
    Pediatr Endocrinol Diabetes Metab; 2022; 28(1):64-74. PubMed ID: 35307998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserved Sleep for the Same Level of Respiratory Disturbance in Children with Prader-Willi Syndrome.
    Tan Q; He XTT; Kang S; Haqq AM; MacLean JE
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy.
    Ludwig NG; Radaeli RF; Silva MM; Romero CM; Carrilho AJ; Bessa D; Macedo DB; Oliveira ML; Latronico AC; Mazzuco TL
    Arch Endocrinol Metab; 2016; 60(6):596-600. PubMed ID: 27982202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome.
    Dağdeviren Çakır A; Baş F; Akın O; Şıklar Z; Özcabı B; Berberoğlu M; Kardelen AD; Bayramoğlu E; Poyrazoğlu Ş; Aydın M; Törel Ergür A; Gökşen D; Bolu S; Aycan Z; Tüysüz B; Ercan O; Evliyaoğlu O
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):308-319. PubMed ID: 33565750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome.
    Corrias A; Grugni G; Crinò A; Di Candia S; Chiabotto P; Cogliardi A; Chiumello G; De Medici C; Spera S; Gargantini L; Iughetti L; Luce A; Mariani B; Ragusa L; Salvatoni A; Andrulli S; Mussa A; Beccaria L;
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):843-50. PubMed ID: 22150958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.
    Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
    Acta Paediatr; 1998 Jan; 87(1):28-31. PubMed ID: 9510443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time for a general approval of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C; Holland AJ; Driscoll DJ;
    Orphanet J Rare Dis; 2021 Feb; 16(1):69. PubMed ID: 33557878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth Hormone Treatment for Prader-Willi Syndrome.
    Tauber M; Diene G; Molinas C
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):91-99. PubMed ID: 30378786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone treatment for adults with Prader-Willi syndrome: another point of view.
    Hirsch HJ; Gross-Tsur V
    Orphanet J Rare Dis; 2021 Aug; 16(1):337. PubMed ID: 34344408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
    J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
    Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
    Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone and respiratory compromise in Prader-Willi Syndrome.
    Wilson SS; Cotterill AM; Harris MA
    Arch Dis Child; 2006 Apr; 91(4):349-50. PubMed ID: 16551791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.
    Eldar-Geva T; Hirsch HJ; Benarroch F; Rubinstein O; Gross-Tsur V
    Eur J Endocrinol; 2010 Feb; 162(2):377-84. PubMed ID: 19946044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.